<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Vitiligo from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Vitiligo news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 17:45:51 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Vitiligo" rel="self" type="application/rss+xml" />

	
<item><title>Simplified Cellular Grafting for Treatment of Vitiligo and Piebaldism: The "6-Well Plate" Technique</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4004215&amp;HITNO=0&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4004215&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519859688%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4004215&amp;HITNO=0&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4004215&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519859688%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MDLinx:</description></item>
<item><title>PhotoMedex Announces Results of Special Meeting of Stockholders</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007226&amp;HITNO=1&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007226&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521058934%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007226&amp;HITNO=1&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007226&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521058934%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>PhotoMedex Announces Results of Special Meeting of Stockholders</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4006389&amp;HITNO=2&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4006389&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520703761%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4006389&amp;HITNO=2&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4006389&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520703761%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>Regressing metastatic melanoma and vitiligo-like depigmentation in an Indigenous Australian</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3988723&amp;HITNO=3&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3988723&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2511434544%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3988723&amp;HITNO=3&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3988723&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2511434544%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medical Journal of Australia:</description></item>
<item><title>PhotoMedex Regains Nasdaq Compliance</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3944263&amp;HITNO=4&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3944263&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2486438045%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3944263&amp;HITNO=4&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3944263&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2486438045%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>PhotoMedex Regains Nasdaq Compliance</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3941942&amp;HITNO=5&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3941942&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485634694%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3941942&amp;HITNO=5&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3941942&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485634694%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Vichy offers corrective stick</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3940490&amp;HITNO=6&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3940490&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485114111%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3940490&amp;HITNO=6&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3940490&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485114111%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Chemist+Druggist:</description></item>
<item><title>Lerner Medical Devices' Levia receives FDA clearance</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3862966&amp;HITNO=7&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3862966&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2445279230%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3862966&amp;HITNO=7&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3862966&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2445279230%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Levia(R) for Personal Targeted Phototherapy(TM) Treatment of Psoriasis Receives FDA 510 (k) Clearance</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3861654&amp;HITNO=8&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3861654&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2444543805%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3861654&amp;HITNO=8&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3861654&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2444543805%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Levia(R) for Personal Targeted Phototherapy(TM) Treatment of Psoriasis Receives FDA 510 (k) Clearance</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3859363&amp;HITNO=9&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3859363&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443642794%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3859363&amp;HITNO=9&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Vitiligo&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3859363&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443642794%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
</channel></rss>